NYSE: FDSFactset Research Systems Inc Stock
$428.71+5.81 (+1.37%)
Updated Apr 29, 2025
FDS Price
$428.71
Fair Value Price
N/A
Market Cap
$16.27B
52 Week Low
$391.69
52 Week High
$499.87
P/E
30.06x
P/B
7.91x
P/S
7.79x
PEG
2.53x
Dividend Yield
0.73%
Revenue
$2.25B
Earnings
$542.51M
Gross Margin
54.1%
Operating Margin
31.96%
Profit Margin
24.1%
Debt to Equity
1.06
Operating Cash Flow
$662M
Beta
0.78
Next Earnings
Jun 19, 2025
Ex-Dividend
N/A
Next Dividend
N/A
FDS Overview
FactSet Research Systems Inc. is a financial data and software company. FactSet provides client support & learning, implementation services, business advisory, data delivery, index services, portfolio data management, and transition services. FactSet's competitors include Bloomberg L.P., Refinitiv, and S&P Global. The company was founded in 1978 and is headquartered in Norwalk, CT.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FDS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Financial Datum & Stock Exchange
Industry Rating
C
FDS
Ranked#6 of 11
Ranked#6 of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $75.94 | C | |
| $282.33 | C | |
| $40.41 | C |
Be the first to know about important FDS news, forecast changes, insider trades & much more!
FDS News
Overview
Due Diligence Score
–
Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FDS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FDS ($428.71) is trading above its intrinsic value of $140.17, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FDS is poor value based on its earnings relative to its share price (30.06x), compared to the US market average (29.19x)
P/E vs Market Valuation
FDS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more FDS due diligence checks available for Premium users.
Valuation
FDS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.06x
Industry
32.54x
Market
29.19x
FDS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FDS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FDS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.91x
Industry
5.01x
FDS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FDS price to earnings growth (PEG)
For valuing profitable companies with growth potential
FDS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
FDS's financial health
Profit margin
Revenue
$570.7M
Net Income
$144.9M
Profit Margin
25.4%
FDS's Earnings (EBIT) of $720.48M... subscribe to Premium to read more.
Interest Coverage Financials
FDS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.2B
Liabilities
$2.2B
Debt to equity
1.06
FDS's short-term assets ($707.64M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FDS's long-term liabilities ($1.70B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FDS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FDS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$174.0M
Investing
-$193.1M
Financing
$24.5M
FDS's operating cash flow ($661.72M)... subscribe to Premium to read more.
Debt Coverage Financials
FDS vs Financial Datum & Stock Exchange Stocks
Factset Research Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.